College Seminar Features
Look at Oncology Agents
"Development of New Agents in Oncology" will be explored at an all college seminar scheduled for Thursday, November 21 at the College of Pharmacy. The free event is open to the public and begins at 4 p.m. in the South Pharmacy Building's PHR 3.106 .
Guest speaker for the seminar is Dr. Steve Weitman with the Cancer Therapy and Research Center (CTRC) at The University of Texas Health Science Center San Antonio (UTHSCSA). Weitman serves as director of the CTRC's Institute for Drug Development. He also serves as associate director for clinical research and is the association's AT&T Distinguished Chair in Drug Development.
From 1996-2001, Weitman worked at the CTRC as program director within the Institute for Drug Development. He has served as a full-time consultant to academic organizations and industry focusing on bringing new anticancer therapies to patients. He was previously the chief medical officer and senior vice president at ILEX Oncology.
At the UTHSCSA, he works to create and support oncology drug development, build experimental clinical (phase I and phase II) programs, and develop individualized patient cancer treatment initiatives involving both laboratory and clinical teams.
He is board certified with the American Board of Pediatrics having attending medical school at the Medical College of Wisconsin. He completed an internship, a residency, and a fellowship at the University of Texas Southwestern Medical Center in Dallas.